NIMH supported science and NIMH researchers helped pave the way for the development of ketamine—a groundbreaking treatment that has improved the lives of those who are impacted by treatment-resistant depression.
Source: nimh

During this lecture, Julianne Holt-Lunstad, Ph.D., will discuss the health impacts of having or lacking social connection.
Source: nimh

During this lecture, Julianne Holt-Lunstad, Ph.D., will discuss the health impacts of having or lacking social connection.
Source: nimh

This technical assistance webinar is for prospective applicants of the Notice of Funding Opportunity: The Scalable and Systematic Neurobiology of Psychiatric and Neurodevelopmental Disorder Risk Genes.
Source: nimh

The winner of the 2023 James S. Jackson Memorial Award, Lisa Bowleg, Ph.D., M.A. will discuss her research on reducing health inequities.
Source: nimh

A group of international scientists have mapped the genetic, cellular, and structural makeup of the human brain and the nonhuman primate brain, allowing for a deeper knowledge of the cellular basis of brain function and dysfunction, helping pave the way for a new generation of precision therapeutics for people with mental disorders and other disorders of the brain.
Source: nimh

Ketamine. For some people with treatment-resistant depression, this experimental therapy proved to be more than just life-changing—it was lifesaving. But how did a drug once used as a battlefield anesthetic evolve into esketamine, a treatment for major depressive illnesses? In this episode, we'll talk with Dr. Carlos Zarate Jr., who helped lay the groundwork for esketamine for treatment-resistant depression. We'll learn the history behind the development of esketamine, how it can help with depression, and what the future holds for this innovative line of clinical research.
Source: nimh

This pre-application webinar is for prospective applicants of RFA-MH-24-100: Precision HIV Health: Integrating Data and Implementation Science to Accelerate HIV Prevention and Treatment.
Source: nimh

NIH is funding a first-of-its-kind community-led research program to study ways to address the underlying structural factors within communities that affect health, such as access to safe spaces, healthy food, employment opportunities, transportation, and quality health care.
Source: nimh

This technical assistance webinar will be held for prospective applicants of the following Notice of Funding Opportunities (NOFOs): Approaches to Identifying Preteen Suicide Risk and Protective Factors (R01 Clinical Trial Not Allowed) and Data Coordinating Center for Approaches to Identifying Preteen Suicide Risk and Protective Factors (U24 Clinical Trial Not Allowed).
Source: nimh